Armata Pharmaceuticals, Inc.
ARMP
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$10.63
FAIR PRICE
$7.85
MARGIN
$2.78
P/E Ratio
N/A
Div. Yield
N/A
ROE
158.9%
Exceptional
Market Cap
$360M
Small-cap
COMING SOON
Get notified when ARMP's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Deborah L. Birx
COUNTRY
US
HEADQUARTERS
Marina del Rey
SECTOR
Healthcare
EXCHANGE
AMEX
METHODOLOGY
How we calculate ARMP's fair price
Armata Pharmaceuticals, Inc.'s fair price of $7.85 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $10.63, ARMP trades 26.2% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting ARMP's risk profile.
RELATIVE · 30%
Comparing ARMP's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for ARMP, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate ARMP's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for ARMP.
Explore on BuliosFAQ
What is the fair price of ARMP?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Armata Pharmaceuticals, Inc. is $7.85. At the current market price of $10.63, ARMP trades 26.2% above its calculated fair value.
Is ARMP overvalued or undervalued?+
Armata Pharmaceuticals, Inc. is currently overvalued based on our valuation model. The stock trades at $10.63, which is 26.2% above the fair price of $7.85.
How often is ARMP's fair price updated?+
We update fair price calculations for ARMP daily after market close. The current fair price of $7.85 incorporates the latest market data and sector multiples.
What factors affect ARMP's fair price calculation?+
ARMP's fair price of $7.85 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 158.9%.
Is ARMP a good buy right now?+
At $10.63, ARMP trades 26.2% above our fair value estimate of $7.85. The stock is currently overvalued. ROE stands at 158.9% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.
Does ARMP pay dividends?+
ARMP does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.